

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.08495139 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.95878615 |
| 3 | vocalization behavior (GO:0071625) | 5.90530647 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.79448852 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.71902207 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.71327171 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.44504425 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.30497589 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.23046963 |
| 10 | protein localization to synapse (GO:0035418) | 5.15345118 |
| 11 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.15133449 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.06528370 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 4.90751916 |
| 14 | dendritic spine morphogenesis (GO:0060997) | 4.87429927 |
| 15 | glutamate secretion (GO:0014047) | 4.83272359 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.78193171 |
| 17 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.73143346 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.72611341 |
| 19 | behavioral response to nicotine (GO:0035095) | 4.69896884 |
| 20 | exploration behavior (GO:0035640) | 4.69846328 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.66339303 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 4.61980390 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 4.59629890 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 4.43652795 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.38727892 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.29288191 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 4.28999715 |
| 28 | nucleobase catabolic process (GO:0046113) | 4.23439183 |
| 29 | neurotransmitter secretion (GO:0007269) | 4.22932914 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.20840837 |
| 31 | neuronal action potential propagation (GO:0019227) | 4.16846906 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 4.14202194 |
| 33 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.12098143 |
| 34 | neuron recognition (GO:0008038) | 4.10509510 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.07491715 |
| 36 | long-term memory (GO:0007616) | 4.03928473 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.99724869 |
| 38 | establishment of mitochondrion localization (GO:0051654) | 3.91132714 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.87895341 |
| 40 | axonal fasciculation (GO:0007413) | 3.75190862 |
| 41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.73499469 |
| 42 | regulation of synaptic plasticity (GO:0048167) | 3.73463183 |
| 43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71626914 |
| 44 | transmission of nerve impulse (GO:0019226) | 3.71457592 |
| 45 | gamma-aminobutyric acid transport (GO:0015812) | 3.70878411 |
| 46 | auditory behavior (GO:0031223) | 3.69323088 |
| 47 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.67688079 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.67506431 |
| 49 | proline transport (GO:0015824) | 3.66656303 |
| 50 | postsynaptic membrane organization (GO:0001941) | 3.61237544 |
| 51 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.59128035 |
| 52 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.57596469 |
| 53 | dendritic spine organization (GO:0097061) | 3.51010471 |
| 54 | neuromuscular process controlling balance (GO:0050885) | 3.50839485 |
| 55 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.50750013 |
| 56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.49938370 |
| 57 | regulation of dendritic spine development (GO:0060998) | 3.49848526 |
| 58 | positive regulation of dendritic spine development (GO:0060999) | 3.49751197 |
| 59 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.48114545 |
| 60 | neuromuscular synaptic transmission (GO:0007274) | 3.47775458 |
| 61 | dendrite morphogenesis (GO:0048813) | 3.47609164 |
| 62 | prepulse inhibition (GO:0060134) | 3.46341750 |
| 63 | neurotransmitter transport (GO:0006836) | 3.44614178 |
| 64 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.42037543 |
| 65 | synaptic vesicle endocytosis (GO:0048488) | 3.41567953 |
| 66 | regulation of synapse maturation (GO:0090128) | 3.39195009 |
| 67 | long-term synaptic potentiation (GO:0060291) | 3.38504919 |
| 68 | positive regulation of neurotransmitter transport (GO:0051590) | 3.37722318 |
| 69 | axon ensheathment in central nervous system (GO:0032291) | 3.37118444 |
| 70 | central nervous system myelination (GO:0022010) | 3.37118444 |
| 71 | behavioral fear response (GO:0001662) | 3.36274151 |
| 72 | behavioral defense response (GO:0002209) | 3.36274151 |
| 73 | regulation of vesicle fusion (GO:0031338) | 3.36030992 |
| 74 | neuronal ion channel clustering (GO:0045161) | 3.35064059 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.34620086 |
| 76 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.34413124 |
| 77 | mitochondrion transport along microtubule (GO:0047497) | 3.34413124 |
| 78 | response to auditory stimulus (GO:0010996) | 3.33641963 |
| 79 | neurofilament cytoskeleton organization (GO:0060052) | 3.31662118 |
| 80 | activation of protein kinase A activity (GO:0034199) | 3.31593660 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.31407411 |
| 82 | response to histamine (GO:0034776) | 3.29121393 |
| 83 | learning (GO:0007612) | 3.28260950 |
| 84 | membrane depolarization (GO:0051899) | 3.27832761 |
| 85 | adult walking behavior (GO:0007628) | 3.26349424 |
| 86 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.24808096 |
| 87 | presynaptic membrane assembly (GO:0097105) | 3.24114616 |
| 88 | cellular potassium ion homeostasis (GO:0030007) | 3.22665113 |
| 89 | cell differentiation in hindbrain (GO:0021533) | 3.21749033 |
| 90 | regulation of neurotransmitter levels (GO:0001505) | 3.20245291 |
| 91 | positive regulation of synapse assembly (GO:0051965) | 3.20030703 |
| 92 | membrane hyperpolarization (GO:0060081) | 3.19993842 |
| 93 | cell migration in hindbrain (GO:0021535) | 3.19392643 |
| 94 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.17450594 |
| 95 | fear response (GO:0042596) | 3.15086719 |
| 96 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.14558441 |
| 97 | regulation of female receptivity (GO:0045924) | 3.13805166 |
| 98 | intraspecies interaction between organisms (GO:0051703) | 3.13417695 |
| 99 | social behavior (GO:0035176) | 3.13417695 |
| 100 | regulation of glutamate secretion (GO:0014048) | 3.13356046 |
| 101 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.12208847 |
| 102 | synapse assembly (GO:0007416) | 3.12061419 |
| 103 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.11491503 |
| 104 | regulation of neurotransmitter transport (GO:0051588) | 3.10422420 |
| 105 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.10388997 |
| 106 | cerebellar granule cell differentiation (GO:0021707) | 3.09307684 |
| 107 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.09014819 |
| 108 | dopamine receptor signaling pathway (GO:0007212) | 3.05811876 |
| 109 | presynaptic membrane organization (GO:0097090) | 3.03415657 |
| 110 | regulation of synaptic transmission (GO:0050804) | 3.03216509 |
| 111 | behavioral response to cocaine (GO:0048148) | 3.02607546 |
| 112 | positive regulation of synaptic transmission (GO:0050806) | 3.02173239 |
| 113 | membrane depolarization during action potential (GO:0086010) | 3.01354473 |
| 114 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97515387 |
| 115 | innervation (GO:0060384) | 2.96799579 |
| 116 | mechanosensory behavior (GO:0007638) | 2.94527790 |
| 117 | neuromuscular process (GO:0050905) | 2.94164306 |
| 118 | axon extension (GO:0048675) | 2.90951631 |
| 119 | potassium ion homeostasis (GO:0055075) | 2.89846924 |
| 120 | serotonin metabolic process (GO:0042428) | 2.85629840 |
| 121 | protein polyglutamylation (GO:0018095) | 2.84414019 |
| 122 | synaptic transmission (GO:0007268) | 2.84190113 |
| 123 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.83209150 |
| 124 | synapse organization (GO:0050808) | 2.79408956 |
| 125 | startle response (GO:0001964) | 2.78051257 |
| 126 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.74980423 |
| 127 | calcium ion-dependent exocytosis (GO:0017156) | 2.73371454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.42388325 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.51805870 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.19703464 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19337025 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04233193 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84517948 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78316298 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78316298 |
| 9 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.76918968 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72465243 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.69243320 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.67457409 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57683265 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.54692625 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52414796 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51831971 |
| 17 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43665777 |
| 18 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.39063749 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37311832 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31162008 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27950521 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.27946514 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.25219176 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.22576687 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.12159510 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11671141 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.06645799 |
| 28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.01571134 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97419757 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95408620 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94427479 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88267459 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78551933 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67503564 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.66515735 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64841416 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58278603 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51867976 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42316419 |
| 40 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42051878 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41957628 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39663285 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39522474 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38593285 |
| 45 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.33616072 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32357031 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30774137 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30295667 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28690128 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28616100 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26634472 |
| 52 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.24050894 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23460103 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22532971 |
| 55 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20866899 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20687506 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18774604 |
| 58 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.16787125 |
| 59 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16421614 |
| 60 | AR_19668381_ChIP-Seq_PC3_Human | 1.16312101 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15952784 |
| 62 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.14666364 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13856716 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13589161 |
| 65 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13492604 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11092461 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10642189 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10618874 |
| 69 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.10061242 |
| 70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09479020 |
| 71 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05336456 |
| 72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04950900 |
| 73 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04425825 |
| 74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03270509 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02659564 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02637092 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00907202 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00569613 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00234912 |
| 80 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00147918 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99251700 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98710322 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98579874 |
| 84 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.97470403 |
| 85 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.97073591 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96634338 |
| 87 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96561061 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96334531 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96312903 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95924986 |
| 91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95525020 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94869696 |
| 93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94792032 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94032111 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93295927 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93295927 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91624190 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91112612 |
| 99 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90539747 |
| 100 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90243875 |
| 101 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90145490 |
| 102 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89878124 |
| 103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89247309 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88700886 |
| 105 | JUN_21703547_ChIP-Seq_K562_Human | 0.88680104 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88023835 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87068751 |
| 108 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86969472 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86824727 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86798624 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86670629 |
| 112 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.86574529 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84546101 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82708935 |
| 115 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.81657270 |
| 116 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.80545651 |
| 117 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.80262115 |
| 118 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.80262115 |
| 119 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77614733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.80501121 |
| 2 | MP0003880_abnormal_central_pattern | 5.08535050 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.25620338 |
| 4 | MP0004270_analgesia | 3.77366000 |
| 5 | MP0002822_catalepsy | 3.55186133 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.53025278 |
| 7 | MP0009745_abnormal_behavioral_response | 3.50165750 |
| 8 | MP0002064_seizures | 3.11357893 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.01166595 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.90536943 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.89043912 |
| 12 | MP0009046_muscle_twitch | 2.79619931 |
| 13 | MP0001486_abnormal_startle_reflex | 2.63674655 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.55107057 |
| 15 | MP0002272_abnormal_nervous_system | 2.48172601 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.26200452 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.18278101 |
| 18 | MP0002736_abnormal_nociception_after | 2.14302579 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.11327660 |
| 20 | MP0000778_abnormal_nervous_system | 2.07667840 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.02713787 |
| 22 | MP0001970_abnormal_pain_threshold | 1.93143235 |
| 23 | MP0002184_abnormal_innervation | 1.85719576 |
| 24 | MP0002557_abnormal_social/conspecific_i | 1.84599145 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.83631938 |
| 26 | MP0003123_paternal_imprinting | 1.81537737 |
| 27 | MP0004811_abnormal_neuron_physiology | 1.80230532 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.80220169 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.78698259 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.78290318 |
| 31 | MP0004924_abnormal_behavior | 1.78290318 |
| 32 | MP0003329_amyloid_beta_deposits | 1.74078817 |
| 33 | MP0001529_abnormal_vocalization | 1.72980486 |
| 34 | MP0008569_lethality_at_weaning | 1.66035165 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.64693082 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.63458569 |
| 37 | MP0001984_abnormal_olfaction | 1.62890542 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.62019772 |
| 39 | MP0003879_abnormal_hair_cell | 1.54922141 |
| 40 | MP0004858_abnormal_nervous_system | 1.54290045 |
| 41 | MP0000955_abnormal_spinal_cord | 1.54096043 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.51437473 |
| 43 | MP0003787_abnormal_imprinting | 1.48135930 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.43632136 |
| 45 | MP0003122_maternal_imprinting | 1.41784388 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.41762766 |
| 47 | MP0004885_abnormal_endolymph | 1.40802387 |
| 48 | MP0001905_abnormal_dopamine_level | 1.37252287 |
| 49 | MP0001188_hyperpigmentation | 1.34441334 |
| 50 | MP0004133_heterotaxia | 1.25462454 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.23692843 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.22371849 |
| 53 | MP0003633_abnormal_nervous_system | 1.20508839 |
| 54 | MP0002152_abnormal_brain_morphology | 1.18996248 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.15951213 |
| 56 | MP0005409_darkened_coat_color | 1.15206806 |
| 57 | MP0004142_abnormal_muscle_tone | 1.12027073 |
| 58 | MP0003631_nervous_system_phenotype | 1.03235889 |
| 59 | MP0004130_abnormal_muscle_cell | 1.01615350 |
| 60 | MP0008872_abnormal_physiological_respon | 1.00339056 |
| 61 | MP0009379_abnormal_foot_pigmentation | 0.99591031 |
| 62 | MP0002069_abnormal_eating/drinking_beha | 0.98343222 |
| 63 | MP0001986_abnormal_taste_sensitivity | 0.96730481 |
| 64 | MP0000751_myopathy | 0.93849492 |
| 65 | MP0003938_abnormal_ear_development | 0.92794854 |
| 66 | MP0004742_abnormal_vestibular_system | 0.91388742 |
| 67 | MP0005499_abnormal_olfactory_system | 0.90943976 |
| 68 | MP0005394_taste/olfaction_phenotype | 0.90943976 |
| 69 | MP0010386_abnormal_urinary_bladder | 0.89970231 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 0.89399452 |
| 71 | MP0000049_abnormal_middle_ear | 0.89085209 |
| 72 | MP0008874_decreased_physiological_sensi | 0.87918419 |
| 73 | MP0001177_atelectasis | 0.87823006 |
| 74 | MP0002229_neurodegeneration | 0.86334571 |
| 75 | MP0004085_abnormal_heartbeat | 0.85228459 |
| 76 | MP0000566_synostosis | 0.84810890 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 0.84659941 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.84628495 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.84599741 |
| 80 | MP0003283_abnormal_digestive_organ | 0.81623280 |
| 81 | MP0005535_abnormal_body_temperature | 0.80332251 |
| 82 | MP0005551_abnormal_eye_electrophysiolog | 0.80208243 |
| 83 | MP0003075_altered_response_to | 0.79314888 |
| 84 | MP0006292_abnormal_olfactory_placode | 0.79173722 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 0.77344611 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.76617305 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.76487925 |
| 88 | MP0003634_abnormal_glial_cell | 0.75678444 |
| 89 | MP0006072_abnormal_retinal_apoptosis | 0.74371705 |
| 90 | MP0002163_abnormal_gland_morphology | 0.73863464 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 0.73789773 |
| 92 | MP0002160_abnormal_reproductive_system | 0.73596687 |
| 93 | MP0005195_abnormal_posterior_eye | 0.73594128 |
| 94 | MP0000604_amyloidosis | 0.70342079 |
| 95 | MP0003632_abnormal_nervous_system | 0.69637864 |
| 96 | MP0002102_abnormal_ear_morphology | 0.69512563 |
| 97 | MP0003861_abnormal_nervous_system | 0.69490903 |
| 98 | MP0000920_abnormal_myelination | 0.68770517 |
| 99 | MP0002928_abnormal_bile_duct | 0.68018732 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.66508799 |
| 101 | MP0003690_abnormal_glial_cell | 0.65879834 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.65750634 |
| 103 | MP0002751_abnormal_autonomic_nervous | 0.64962070 |
| 104 | MP0005253_abnormal_eye_physiology | 0.64040865 |
| 105 | MP0003119_abnormal_digestive_system | 0.63955102 |
| 106 | MP0002638_abnormal_pupillary_reflex | 0.63633861 |
| 107 | MP0001664_abnormal_digestion | 0.62907338 |
| 108 | MP0003011_delayed_dark_adaptation | 0.62887613 |
| 109 | MP0001485_abnormal_pinna_reflex | 0.61084839 |
| 110 | MP0002090_abnormal_vision | 0.60710651 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.59814915 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.59581015 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.58047163 |
| 114 | MP0003121_genomic_imprinting | 0.57921816 |
| 115 | MP0002234_abnormal_pharynx_morphology | 0.57413157 |
| 116 | MP0005187_abnormal_penis_morphology | 0.55609550 |
| 117 | MP0004510_myositis | 0.55168650 |
| 118 | MP0001943_abnormal_respiration | 0.55024616 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.54303331 |
| 120 | MP0010769_abnormal_survival | 0.54108156 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.53032240 |
| 122 | MP0010770_preweaning_lethality | 0.52995565 |
| 123 | MP0002082_postnatal_lethality | 0.52995565 |
| 124 | MP0000026_abnormal_inner_ear | 0.52952646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.83325917 |
| 2 | Myokymia (HP:0002411) | 7.43047961 |
| 3 | Focal seizures (HP:0007359) | 5.97507209 |
| 4 | Visual hallucinations (HP:0002367) | 5.10589475 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.81670072 |
| 6 | Febrile seizures (HP:0002373) | 4.12847284 |
| 7 | Atonic seizures (HP:0010819) | 4.12445021 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.00902967 |
| 9 | Absence seizures (HP:0002121) | 3.99834819 |
| 10 | Broad-based gait (HP:0002136) | 3.91870064 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.81087568 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.75722443 |
| 13 | Poor eye contact (HP:0000817) | 3.73370410 |
| 14 | Dialeptic seizures (HP:0011146) | 3.71073565 |
| 15 | Ankle clonus (HP:0011448) | 3.47861447 |
| 16 | Action tremor (HP:0002345) | 3.47408380 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.39008269 |
| 18 | Mutism (HP:0002300) | 3.34814894 |
| 19 | Hyperventilation (HP:0002883) | 3.30619213 |
| 20 | Amblyopia (HP:0000646) | 3.29192172 |
| 21 | Abnormal social behavior (HP:0012433) | 3.28519401 |
| 22 | Impaired social interactions (HP:0000735) | 3.28519401 |
| 23 | Depression (HP:0000716) | 3.15477570 |
| 24 | Papilledema (HP:0001085) | 3.14236115 |
| 25 | Abnormal eating behavior (HP:0100738) | 3.10578429 |
| 26 | Drooling (HP:0002307) | 3.09192227 |
| 27 | Excessive salivation (HP:0003781) | 3.09192227 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.09139659 |
| 29 | Anxiety (HP:0000739) | 3.08572810 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 3.06723056 |
| 31 | Dysdiadochokinesis (HP:0002075) | 2.94597826 |
| 32 | Torticollis (HP:0000473) | 2.92147827 |
| 33 | Dysmetria (HP:0001310) | 2.91811789 |
| 34 | Hemiparesis (HP:0001269) | 2.85905874 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 2.85389531 |
| 36 | Stereotypic behavior (HP:0000733) | 2.80574802 |
| 37 | Truncal ataxia (HP:0002078) | 2.80454129 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.80095673 |
| 39 | Limb dystonia (HP:0002451) | 2.79446657 |
| 40 | Progressive inability to walk (HP:0002505) | 2.76648311 |
| 41 | Focal dystonia (HP:0004373) | 2.74038388 |
| 42 | Polyphagia (HP:0002591) | 2.72998237 |
| 43 | Gait imbalance (HP:0002141) | 2.72640238 |
| 44 | Postural instability (HP:0002172) | 2.70904725 |
| 45 | Urinary urgency (HP:0000012) | 2.70164092 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.70137424 |
| 47 | Genetic anticipation (HP:0003743) | 2.67721142 |
| 48 | Nephronophthisis (HP:0000090) | 2.61525571 |
| 49 | Spastic gait (HP:0002064) | 2.58920327 |
| 50 | Pancreatic fibrosis (HP:0100732) | 2.55762051 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.54062297 |
| 52 | Abnormality of binocular vision (HP:0011514) | 2.50529670 |
| 53 | Diplopia (HP:0000651) | 2.50529670 |
| 54 | Abnormality of the corticospinal tract (HP:0002492) | 2.46732307 |
| 55 | Impaired smooth pursuit (HP:0007772) | 2.46023455 |
| 56 | Craniofacial dystonia (HP:0012179) | 2.43457342 |
| 57 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42410571 |
| 58 | Absent speech (HP:0001344) | 2.42376739 |
| 59 | True hermaphroditism (HP:0010459) | 2.41491212 |
| 60 | Bradykinesia (HP:0002067) | 2.39979560 |
| 61 | Amyotrophic lateral sclerosis (HP:0007354) | 2.36285352 |
| 62 | Termporal pattern (HP:0011008) | 2.34930538 |
| 63 | Insidious onset (HP:0003587) | 2.34930538 |
| 64 | Inability to walk (HP:0002540) | 2.31026786 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.29521030 |
| 66 | Abnormality of midbrain morphology (HP:0002418) | 2.29340419 |
| 67 | Molar tooth sign on MRI (HP:0002419) | 2.29340419 |
| 68 | Megalencephaly (HP:0001355) | 2.28189148 |
| 69 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.26672288 |
| 70 | Type II lissencephaly (HP:0007260) | 2.24186992 |
| 71 | Spastic tetraplegia (HP:0002510) | 2.24132983 |
| 72 | Lissencephaly (HP:0001339) | 2.22735385 |
| 73 | Pachygyria (HP:0001302) | 2.22590929 |
| 74 | Pancreatic cysts (HP:0001737) | 2.20843511 |
| 75 | Impaired vibratory sensation (HP:0002495) | 2.20651451 |
| 76 | Pointed chin (HP:0000307) | 2.17612258 |
| 77 | Intention tremor (HP:0002080) | 2.17523080 |
| 78 | Lower limb muscle weakness (HP:0007340) | 2.16896831 |
| 79 | Scanning speech (HP:0002168) | 2.14605107 |
| 80 | Fetal akinesia sequence (HP:0001989) | 2.13244106 |
| 81 | Obstructive sleep apnea (HP:0002870) | 2.12755166 |
| 82 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.12591641 |
| 83 | Protruding tongue (HP:0010808) | 2.11840582 |
| 84 | Inappropriate behavior (HP:0000719) | 2.11073961 |
| 85 | Annular pancreas (HP:0001734) | 2.10570942 |
| 86 | Hemiplegia (HP:0002301) | 2.10284956 |
| 87 | Medial flaring of the eyebrow (HP:0010747) | 2.09307979 |
| 88 | Lower limb amyotrophy (HP:0007210) | 2.08610828 |
| 89 | Abnormality of salivation (HP:0100755) | 2.07652539 |
| 90 | Retinal dysplasia (HP:0007973) | 2.06976636 |
| 91 | Abnormality of the labia minora (HP:0012880) | 2.06593047 |
| 92 | Sleep apnea (HP:0010535) | 2.04726725 |
| 93 | Status epilepticus (HP:0002133) | 2.04387647 |
| 94 | Generalized myoclonic seizures (HP:0002123) | 2.03995199 |
| 95 | Insomnia (HP:0100785) | 2.01903035 |
| 96 | Abnormality of the renal medulla (HP:0100957) | 2.01422997 |
| 97 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.01212624 |
| 98 | Incomplete penetrance (HP:0003829) | 1.99963804 |
| 99 | Congenital stationary night blindness (HP:0007642) | 1.97301470 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 1.93607670 |
| 101 | Pendular nystagmus (HP:0012043) | 1.93576468 |
| 102 | Agitation (HP:0000713) | 1.93559610 |
| 103 | Apathy (HP:0000741) | 1.93100239 |
| 104 | Failure to thrive in infancy (HP:0001531) | 1.93063422 |
| 105 | Cerebral hypomyelination (HP:0006808) | 1.91358496 |
| 106 | Oligodactyly (hands) (HP:0001180) | 1.90604152 |
| 107 | Ankyloglossia (HP:0010296) | 1.89290857 |
| 108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88464045 |
| 109 | Hyperthyroidism (HP:0000836) | 1.87393041 |
| 110 | Ventricular fibrillation (HP:0001663) | 1.87361602 |
| 111 | Optic nerve hypoplasia (HP:0000609) | 1.84129424 |
| 112 | Hypoplasia of the corpus callosum (HP:0002079) | 1.84027040 |
| 113 | Delusions (HP:0000746) | 1.83798139 |
| 114 | Congenital primary aphakia (HP:0007707) | 1.82931366 |
| 115 | Specific learning disability (HP:0001328) | 1.82849332 |
| 116 | Abnormal EKG (HP:0003115) | 1.82264575 |
| 117 | Blue irides (HP:0000635) | 1.82151859 |
| 118 | Chronic hepatic failure (HP:0100626) | 1.81149337 |
| 119 | Psychosis (HP:0000709) | 1.80595882 |
| 120 | Gait ataxia (HP:0002066) | 1.80570752 |
| 121 | Clonus (HP:0002169) | 1.80503213 |
| 122 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79141729 |
| 123 | Poor suck (HP:0002033) | 1.79064698 |
| 124 | Dysmetric saccades (HP:0000641) | 1.76859407 |
| 125 | Autism (HP:0000717) | 1.76788748 |
| 126 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.76169251 |
| 127 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.76169251 |
| 128 | Lower limb asymmetry (HP:0100559) | 1.74701360 |
| 129 | Akinesia (HP:0002304) | 1.74181348 |
| 130 | Hypoplasia of the brainstem (HP:0002365) | 1.73886676 |
| 131 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.73886676 |
| 132 | Restlessness (HP:0000711) | 1.71976867 |
| 133 | Intellectual disability, severe (HP:0010864) | 1.70567655 |
| 134 | Vaginal atresia (HP:0000148) | 1.70426936 |
| 135 | Genital tract atresia (HP:0001827) | 1.67934150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.04069897 |
| 2 | NTRK3 | 4.51022110 |
| 3 | MARK1 | 3.88180498 |
| 4 | MAP3K9 | 3.73340643 |
| 5 | DAPK2 | 2.85564518 |
| 6 | MAP3K4 | 2.76336329 |
| 7 | MINK1 | 2.59619598 |
| 8 | MAP2K7 | 2.34400548 |
| 9 | PAK6 | 2.17129499 |
| 10 | NTRK2 | 2.16918722 |
| 11 | KSR2 | 1.96089693 |
| 12 | RIPK4 | 1.93555490 |
| 13 | PRKD3 | 1.92810604 |
| 14 | TNIK | 1.90768837 |
| 15 | SIK2 | 1.84725422 |
| 16 | KSR1 | 1.83943777 |
| 17 | DAPK1 | 1.80848783 |
| 18 | MAP3K12 | 1.79822839 |
| 19 | MAP2K4 | 1.68823953 |
| 20 | CASK | 1.65390202 |
| 21 | CDK5 | 1.62411412 |
| 22 | CAMKK1 | 1.61015121 |
| 23 | PNCK | 1.58366616 |
| 24 | NTRK1 | 1.56109660 |
| 25 | MAPK13 | 1.54606921 |
| 26 | PRPF4B | 1.52993419 |
| 27 | PLK2 | 1.36778244 |
| 28 | FES | 1.29994128 |
| 29 | GRK5 | 1.26044017 |
| 30 | TYRO3 | 1.24752675 |
| 31 | UHMK1 | 1.20767796 |
| 32 | PRKCG | 1.14625797 |
| 33 | ARAF | 1.14596078 |
| 34 | CDK19 | 1.10319046 |
| 35 | STK38 | 1.06122166 |
| 36 | ADRBK2 | 1.03747523 |
| 37 | MAP3K2 | 0.99399414 |
| 38 | PHKG2 | 0.99316417 |
| 39 | PHKG1 | 0.99316417 |
| 40 | TAOK1 | 0.99075676 |
| 41 | CAMK2A | 0.99018577 |
| 42 | CDK18 | 0.97804426 |
| 43 | WNK4 | 0.97686562 |
| 44 | FRK | 0.97303914 |
| 45 | CDK15 | 0.94745890 |
| 46 | LATS2 | 0.92395326 |
| 47 | MARK2 | 0.91826349 |
| 48 | CDK14 | 0.90528471 |
| 49 | STK11 | 0.89431695 |
| 50 | CAMK1 | 0.88284900 |
| 51 | CAMK2B | 0.87412462 |
| 52 | MAP3K11 | 0.85685391 |
| 53 | MAP3K13 | 0.85395595 |
| 54 | GRK1 | 0.84361340 |
| 55 | RAF1 | 0.83980299 |
| 56 | CDK11A | 0.83498156 |
| 57 | PINK1 | 0.83426256 |
| 58 | EPHB2 | 0.81240962 |
| 59 | PTK2B | 0.81010980 |
| 60 | DYRK1A | 0.77359635 |
| 61 | CSNK1G2 | 0.75429830 |
| 62 | PAK3 | 0.74817187 |
| 63 | SGK494 | 0.74278390 |
| 64 | SGK223 | 0.74278390 |
| 65 | BMPR2 | 0.73581385 |
| 66 | DYRK1B | 0.70345142 |
| 67 | CAMKK2 | 0.70217110 |
| 68 | SGK1 | 0.69386398 |
| 69 | PRKCH | 0.65026227 |
| 70 | RET | 0.63268114 |
| 71 | FGR | 0.62331524 |
| 72 | OXSR1 | 0.59919072 |
| 73 | CSNK1G3 | 0.59490848 |
| 74 | ALK | 0.58988982 |
| 75 | PRKCZ | 0.56487403 |
| 76 | SIK3 | 0.55271892 |
| 77 | RPS6KA2 | 0.54392144 |
| 78 | SGK2 | 0.54223771 |
| 79 | PRKACA | 0.53929315 |
| 80 | MAP4K2 | 0.53337781 |
| 81 | BCR | 0.52173458 |
| 82 | CSNK1A1L | 0.52019208 |
| 83 | NME1 | 0.51957093 |
| 84 | DYRK3 | 0.50892265 |
| 85 | FGFR2 | 0.49343415 |
| 86 | CAMK1D | 0.49033201 |
| 87 | FYN | 0.48774508 |
| 88 | PDK1 | 0.48765153 |
| 89 | BMPR1B | 0.48678734 |
| 90 | WNK3 | 0.48327426 |
| 91 | CAMK1G | 0.48312497 |
| 92 | DAPK3 | 0.47363167 |
| 93 | RPS6KA3 | 0.47277252 |
| 94 | PDPK1 | 0.47159544 |
| 95 | MAPK15 | 0.46423982 |
| 96 | INSRR | 0.46106169 |
| 97 | PRKCE | 0.46017222 |
| 98 | CSNK1E | 0.45437431 |
| 99 | TNK2 | 0.44501113 |
| 100 | ERBB2 | 0.43033248 |
| 101 | SGK3 | 0.42332407 |
| 102 | ADRBK1 | 0.41856477 |
| 103 | CSNK1G1 | 0.41621893 |
| 104 | CDC42BPA | 0.40880913 |
| 105 | NEK6 | 0.40839478 |
| 106 | MAP3K6 | 0.40517289 |
| 107 | MAP3K1 | 0.40363542 |
| 108 | CAMK4 | 0.40120813 |
| 109 | MAPK10 | 0.40119569 |
| 110 | CSNK1A1 | 0.39616050 |
| 111 | PRKCI | 0.38911346 |
| 112 | CAMK2D | 0.38894815 |
| 113 | PRKG1 | 0.38144287 |
| 114 | DYRK2 | 0.38057505 |
| 115 | LIMK1 | 0.37996572 |
| 116 | CSNK1D | 0.37226452 |
| 117 | STK39 | 0.37089981 |
| 118 | PKN1 | 0.36752512 |
| 119 | PRKCA | 0.36631733 |
| 120 | MAP2K1 | 0.36399664 |
| 121 | ERBB3 | 0.34559980 |
| 122 | CCNB1 | 0.34318201 |
| 123 | CAMK2G | 0.34047168 |
| 124 | DMPK | 0.34010384 |
| 125 | MAPK8 | 0.33906462 |
| 126 | BRSK1 | 0.33422325 |
| 127 | PRKAA1 | 0.33012154 |
| 128 | PRKCB | 0.32304888 |
| 129 | MAPK12 | 0.31952993 |
| 130 | MAP3K7 | 0.29720985 |
| 131 | FER | 0.29642068 |
| 132 | LMTK2 | 0.29557744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.87422823 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.11550737 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.93116912 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79252533 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.76690393 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72297270 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72084383 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.70892552 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.61774647 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.59727281 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.29732163 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.14807485 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08605816 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.01142469 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.93381528 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.90216685 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86664216 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84760207 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.79950891 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.79083165 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76371842 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.73710804 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.73434367 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68608898 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64648679 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.51611689 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.47549879 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.46620630 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.44728416 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34268894 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34044080 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33051187 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30321914 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28316303 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24889572 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.17019827 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14192844 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13327536 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13164852 |
| 40 | Melanogenesis_Homo sapiens_hsa04916 | 1.11277901 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10020078 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04876299 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03689484 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01423916 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98103071 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 0.94537005 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94045755 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90887924 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85941413 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81487334 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79713276 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.78819465 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77345213 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75732402 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75209872 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75186672 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75057096 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74185903 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74108649 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73767934 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71355463 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70710129 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.69199225 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67675216 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66901387 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66356261 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64734764 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64466219 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63885534 |
| 70 | Alcoholism_Homo sapiens_hsa05034 | 0.63826822 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63274616 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61002160 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57925779 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55788477 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55477658 |
| 76 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55073377 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54331392 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54291278 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54139572 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52025495 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51103959 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51013717 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50972510 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50344574 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50300946 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50143807 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50089964 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49950017 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49913518 |
| 90 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49906814 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49867550 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49707101 |
| 93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49579331 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48735836 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48641243 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.48595007 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47983534 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46547332 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46434823 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46080394 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.45441127 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45422339 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44015641 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40426521 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38790903 |
| 106 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37856406 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37395806 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33900963 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33579017 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33550882 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.32909662 |
| 112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32312458 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31730858 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31065488 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29955348 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29900998 |
| 117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29458482 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28364561 |
| 119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28302314 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.28134391 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28118073 |
| 122 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24398257 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23939369 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23618843 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.22696162 |

